» Articles » PMID: 38586191

Associations of Sleep Disorders with All-cause MCI/dementia and Different Types of Dementia - Clinical Evidence, Potential Pathomechanisms and Treatment Options: A Narrative Review

Overview
Journal Front Neurosci
Date 2024 Apr 8
PMID 38586191
Authors
Affiliations
Soon will be listed here.
Abstract

Due to worldwide demographic change, the number of older persons in the population is increasing. Aging is accompanied by changes of sleep structure, deposition of beta-amyloid (Aß) and tau proteins and vascular changes and can turn into mild cognitive impairment (MCI) as well as dementia. Sleep disorders are discussed both as a risk factor for and as a consequence of MCI/dementia. Cross-sectional and longitudinal population-based as well as case-control studies revealed sleep disorders, especially sleep-disorderded breathing (SDB) and excessive or insufficient sleep durations, as risk factors for all-cause MCI/dementia. Regarding different dementia types, SDB was especially associated with vascular dementia while insomnia/insufficient sleep was related to an increased risk of Alzheimer's disease (AD). Scarce and still inconsistent evidence suggests that therapy of sleep disorders, especially continuous positive airway pressure (CPAP) in SDB, can improve cognition in patients with sleep disorders with and without comorbid dementia and delay onset of MCI/dementia in patients with sleep disorders without previous cognitive impairment. Regarding potential pathomechanisms via which sleep disorders lead to MCI/dementia, disturbed sleep, chronic sleep deficit and SDB can impair glymphatic clearance of beta-amyloid (Aß) and tau which lead to amyloid deposition and tau aggregation resulting in changes of brain structures responsible for cognition. Orexins are discussed to modulate sleep and Aß pathology. Their diurnal fluctuation is suppressed by sleep fragmentation and the expression suppressed at the point of hippocampal atrophy, contributing to the progression of dementia. Additionally, sleep disorders can lead to an increased vascular risk profile and vascular changes such as inflammation, endothelial dysfunction and atherosclerosis which can foster neurodegenerative pathology. There is ample evidence indicating that changes of sleep structure in aging persons can lead to dementia and also evidence that therapy of sleep disorder can improve cognition. Therefore, sleep disorders should be identified and treated early.

Citing Articles

The Brain Toxin Cleansing of Sleep Achieved During Wakefulness.

Arendash G J Clin Med. 2025; 14(3).

PMID: 39941597 PMC: 11818883. DOI: 10.3390/jcm14030926.


Association of reported sleep disturbances with objectively assessed mild cognitive impairment among adults in the United States.

Shen C, Wang H, Djiotsop A, Wiener R, Pathak M, Mitra S SAGE Open Med. 2025; 13:20503121251317912.

PMID: 39925957 PMC: 11803677. DOI: 10.1177/20503121251317912.


Examining Specific Theory-of-Mind Aspects in Amnestic and Non-Amnestic Mild Cognitive Impairment: Their Relationships with Sleep Duration and Cognitive Planning.

Batzikosta A, Moraitou D, Steiropoulos P, Papantoniou G, Kougioumtzis G, Katsouri I Brain Sci. 2025; 15(1).

PMID: 39851425 PMC: 11763451. DOI: 10.3390/brainsci15010057.


Improving Sleep Quality and Well-Being in Institutionalized Older Adults: The Potential of NESA Non-Invasive Neuromodulation Treatment.

Baez-Suarez A, Baez-Suarez V, Saldanha L, Vilchez-Barrera M, Hernandez-Perez A, Medina-Ramirez R Geriatrics (Basel). 2025; 10(1.

PMID: 39846574 PMC: 11755576. DOI: 10.3390/geriatrics10010004.


Association of Sleep Disturbances With Prevalent and Incident Motoric Cognitive Risk Syndrome in Community-Residing Older Adults.

Leroy V, Ayers E, Adhikari D, Verghese J Neurology. 2024; 103(11):e210054.

PMID: 39504508 PMC: 11540459. DOI: 10.1212/WNL.0000000000210054.


References
1.
Foster G, Poulin M, Hanly P . Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol. 2006; 92(1):51-65. DOI: 10.1113/expphysiol.2006.035204. View

2.
Liguori C, Romigi A, Nuccetelli M, Zannino S, Sancesario G, Martorana A . Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurol. 2014; 71(12):1498-505. DOI: 10.1001/jamaneurol.2014.2510. View

3.
Wilfling D, Calo S, Dichter M, Meyer G, Mohler R, Kopke S . Non-pharmacological interventions for sleep disturbances in people with dementia. Cochrane Database Syst Rev. 2023; 1:CD011881. PMC: 9808594. DOI: 10.1002/14651858.CD011881.pub2. View

4.
Guo C, Harshfield E, Markus H . Sleep Characteristics and Risk of Stroke and Dementia: An Observational and Mendelian Randomization Study. Neurology. 2024; 102(5):e209141. PMC: 11067695. DOI: 10.1212/WNL.0000000000209141. View

5.
Ju Y, McLeland J, Toedebusch C, Xiong C, Fagan A, Duntley S . Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013; 70(5):587-93. PMC: 3676720. DOI: 10.1001/jamaneurol.2013.2334. View